Zimbabwe has rejected a significant American health deal valued at 367 million US dollars (272 million pounds) over five years due to Washington's demand for confidential biological samples.
This move became public following a government memo dated December was leaked, which showed President Emmerson Mnangagwa felt the arrangement was "lopsided".
An official spokesman later stated that the United States was requesting biological samples for scientific study and commercial gain while was unwilling to share the benefits from any future medical innovations.
"We will now turn to the difficult and regrettable task of scaling back our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy said the United States had provided over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has appealed for more talks to secure a deal suitable to all parties so the country's vital HIV programme can proceed.
Wider Background
This rejection follows a comparable situation in Kenya, where a court suspended a related health funding agreement following legal challenges were raised about the security of Kenyans' health data.
Since resuming the presidency last year, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
The agency had administered assistance for the US government, but Trump stated its expenditure was "inefficient" and his administration was pursuing direct bilateral deals to enhance openness and responsibility.
According to reports, Sixteen nations in Africa have to date signed these new health pacts, representing over $18.3bn of fresh investment.
Details of the Rejected Agreement
This assistance for Zimbabwe was intended to supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation could have provided immense benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy through American-funded programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"The proposal required Zimbabwe to surrender its biological resources and data indefinitely, without any equivalent guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.
"Put simply, our country would provide the basic resources for scientific discovery with no assurance that the end products would be accessible to our people if a new health crisis arise."
Sovereignty and Global Health
Mangwana further said that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were upending systems already set up through the international health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing system created to manage potential pandemics.
"This mechanism is intended to ensure that when a country contributes its information, the benefits – including medicines and cures – are distributed fairly, not monopolised solely by those with the resources to develop them."
The government's concerns regarding the US deal "are not meant as hostility towards the US," he added.
"We are open to continued dialogue with our US partners on how subsequent collaboration might be structured in a manner that honours the sovereignty and dignity of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the government's concerns, but recommended that talks should continue considering much of the nation's Aids initiatives relied on foreign aid.
"Where specific concerns arise, such as those relating to information security or agreement terms, these can often be addressed via technical clarification and mutually agreed protections," the group said.
This impasse emphasises the continuing tensions between receiving much-needed international aid and safeguarding a country's data in an ever more interconnected world.